GSK Pharma reports Q2 profit at Rs 503 crore Medical Dialogues Bureau1 Nov 2019 3:45 AM GMTGSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
GSK decides to recall antacid Zinetac over safety concern Medical Dialogues Bureau26 Sep 2019 11:24 AM GMTNew Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Wednesday announced recall of ranitidine hydrochloride tablets produced in India using API sourced...
GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore Medical Dialogues Bureau31 Aug 2019 7:24 AM GMTMumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
GSK to fund doctoral programs at Government established Regional Centre for Biotechnology Medical Dialogues Bureau27 Jun 2019 4:00 AM GMTUnder this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs while GSK...
GSK pharma head flags need for speed in high-pressure drug market Medical Dialogues Bureau18 Jun 2019 8:36 AM GMTLONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore Garima21 May 2019 4:00 AM GMTThe company had posted a net profit of Rs 105.55 crore for the corresponding period of the previous fiscal, GSK said in a filing to the BSE.New Delhi:...
GSK expects shingles drug sales to exceed $1.3 billion Garima2 May 2019 3:30 AM GMTFTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
